Faron Pharmaceuticals Oy (LON:FARN – Get Free Report) shares crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of GBX 171.53 ($2.16) and traded as low as GBX 167.70 ($2.11). Faron Pharmaceuticals Oy shares last traded at GBX 167.80 ($2.11), with a volume of 3,575 shares.
Faron Pharmaceuticals Oy Trading Down 4.7 %
The company’s 50-day moving average is GBX 169.79 and its 200-day moving average is GBX 167.61. The company has a quick ratio of 1.09, a current ratio of 1.45 and a debt-to-equity ratio of 922.55. The stock has a market capitalization of £169.48 million, a price-to-earnings ratio of -506.25 and a beta of 0.36.
About Faron Pharmaceuticals Oy
Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.
Featured Articles
- Five stocks we like better than Faron Pharmaceuticals Oy
- The Significance of Brokerage Rankings in Stock Selection
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Top 3 ETFs to Hedge Against Inflation in 2025
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.
